Skip to main content
Equibles
PVLA logo

PVLA · Palvella Therapeutics, Inc. · Metrics

Track PVLA — free

Use PVLA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PVLA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$123.92 +0.96 (+0.78%)
Russell 2000 member Rebalance outlook locked
Market Cap
$1.77B
Shares
14.41M
Volume · Oct 20 263.35K Avg daily vol (3M) 208.37K

PVLA metrics

74 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$123.92
Market cap
$1.77B

Price action

20 metrics
Price change (1W)
-8.5%
Price change (30D)
-19.8%
Price change (3M)
-1.0%
Price change (6M)
-4.9%
Price change (YTD)
+17.5%
Price change (1Y)
+68.1%
Trailing year
Price change (5Y)
—
52-week high
$158.13
52-week low
$70.43
Change from 52-week high
-22.2%
Change from 52-week low
+74.6%
Annualized volatility
83.0%
Annualized volatility (3M)
56.1%
Beta
1.7
RSI (14D)
36.9
Price vs SMA 50
-15.1%
Price vs SMA 200
-1.9%
Avg volume (3M)
212,902
Relative volume
1.3
Average dollar volume
$30.52M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
14.41M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
1,282.0×
reciprocal yield 0.1%
P / book
8.0
reciprocal yield 12.5%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-3.6%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
2.7×
reciprocal yield 36.8%
EV / revenue historical average (5Y)
2.7×
reciprocal yield 36.8%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
—
Operating margin
-27.7%
Trailing 12 months
Net margin
43.7%
Gross profit (TTM)
—
Operating profit (TTM)
−$57.74M
Net income (TTM)
−$61.70M
Trailing 12 months
Diluted EPS (TTM)
$-4.83
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$-4.50
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$-4.83
Operating cash flow per diluted share (TTM)
$-2.85
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
$2.77
Stock compensation per diluted share (TTM)
$0.95
Book value per share
$2.26

Growth

11 metrics
Revenue growth YoY
-100.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$1.35M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+29.9%
Year over year · more shares
Revenue CAGR (3Y)
+13.4%
Revenue CAGR (5Y)
+8.0%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-28.4%
Return on assets
-24.3%
Debt / equity
—
Current ratio
21.2
EBITDA (TTM)
$3.43M
Free cash flow (TTM)
—
Quick ratio
21.2
Interest coverage
—
Net debt / EBITDA
-5.6
Return on invested capital
—
Trailing 12 months
Net cash
$250.58M
Latest balance sheet
Cash & equivalents
$187.80M
Total assets
$253.51M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$36.51M
Capital expenditures (TTM)
$56,000
R&D (TTM)
$35.46M
SG&A (TTM)
—
Stock compensation (TTM)
$12.40M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
198
13F filer change QoQ
+16
Institutional ownership
101.1%
Conviction holders (share of 13F filers)
3.1%
Crowding (high-turnover and private-fund holders)
50.0%
Private-fund adviser ownership
49.1%
Active holders' share change QoQ
+1.5%
Holder tenure
4.6
Price vs estimated holder cost
+103.2%

Ownership (registered funds)

1 metrics
Index-fund ownership
12.3%

Short interest

3 metrics
Short interest
17.5%
Latest settlement · 10.7 days to cover
Days to cover
10.7d
Short-squeeze score
72 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$9.11M
Insider-sentiment score
56 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1583648 CUSIP 697947109 13F (30d) 13 filings 13 filers Visit website Investor relations